Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
SANUWAVE Health Announces 1-For-375 Reverse Stock Split
-
ElevateBio Announces Advancements of its Proprietary Lipid Nanoparticle (LNP) Delivery Platform with Liver Targeting and De-Targeting Potential
-
Brixton Metals Drills 8.00m of 11.37 g/t Gold including 2.00m of 44.43 g/t Gold all within 82.00m of 1.27 g/t Gold at its Trapper Target on the Thorn Project
-
XYZ Media Spotlights Tina Jin’s Affordable Water Filtration System Using Cow Bone Waste in ‘Next Generation of Innovators’ Series
-
Form 8.3 - MUSICMAGPIE PLC
-
Form 8.3 - TRINITY EXPLORATION & PRODUCTION PLC
-
JCS Solutions CEO Selected as a Cyber50 Executive for the First Time
-
ShorePoint Named a Cyber50 GovCon Honoree for Second Year Running
-
Enthusiast’s Luminosity Hosts Invitational Smash Bros Event for over 400,000 Unique Online Viewers
-
Lifeist Announces Conclusion of Consulting Agreement with Singular Narrative Management Ltd.
-
MADD Canada and MPI Deliver Sober Driving Message to Manitoba Students
-
Invivyd to Present PEMGARDA™ (pemivibart) Data at Infectious Disease Week (IDWeek) 2024
-
Emerita Intersects 6.5m of Massive Sulfide Grading 1.1% Copper, 1.1% Lead, 3.1% Zinc, 73.35 g/t Silver And 1.36 g/t Gold at El Cura Deposit, Demonstrating Continuity of Mineralization Along Strike
-
Revolutionizing Lighting: Superior LED Technologies Unveils Industry's Most Efficient Lights, Setting a New Standard
-
Serve Robotics Rolls Out Third-Generation Autonomous Delivery Robot; Platform Upgrade Will Support National Scaling
-
POET Wins “Best in Artificial Intelligence” Honors at 2024 Global Tech Awards
-
Scilex Holding Company Announces that its Board of Directors has Authorized Management to Explore Ways to Maximize the Value of its Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., including by w
-
REPEAT - Court challenge to be heard Thursday re. Ford Government’s expansion & new 30-yr license for Southbridge’s Orchard Villa, for-profit long-term care with reprehensible record
-
2024 ASDSA Top Advocates Chosen
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
The Devon Group Launches the Clear Communicator Awards to Celebrate Excellence in HR Tech Marketing
-
Opthea Files Notice of Annual General Meeting
-
ASDSA Recognizes 2024 Patient Safety Hero Award Honorees
-
Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting
-
Nodenza Venture Partners launched - focus on international early-stage and pre-commercial biotech & medtech opportunities
-
OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain
-
Revolutionizing Lighting: Superior LED Technologies Unveils Industry's Most Efficient Lights, Setting a New Standard
-
Mesa Air Group Reports Third Quarter Fiscal 2024 Results
-
ACELYRIN, INC. Forms Scientific and Patient Advisory Board Featuring Leading Voices in Thyroid Eye Disease
-
Sagimet Biosciences Announces Upcoming Presentations at AASLD - The Liver Meeting® 2024
-
Hydreight Provides Corporate Update Reflecting Significant Growth
-
Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey
-
Barrick Reports Q3 Preliminary Production Results With Continued Improvement at Pueblo Viejo
-
Apellis Announces Oral Presentation at American Society of Nephrology (ASN) Kidney Week on Phase 3 VALIANT Study of Pegcetacoplan in C3G and Primary IC-MPGN
-
Tilray Announces Fall Craft Beer Lineup
-
New York Supreme Court Rules in Favor of Gyrodyne in Article 78 Proceeding
-
Revving Vive’s Highest Velocity Commercialization Engine
-
Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients with Moderate to Severe Systemic Lupus Erythematosus
-
Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo
-
ICPO Foundation funded global “Radiopharmaceutical Trial Finder” developed by WARMTH and Ancora.ai
-
Green Ammo Secures Contracts with U.S. Department of Defense to Deliver Nearly 1,300 E-Blanks Training Kits Amid Global Blank Ammunition Shortage
-
Nodenza Venture Partners launched - focus on international early-stage and pre-commercial biotech & medtech opportunities
-
YieldMax™ ETFs Announces Distributions on FIAT (105.76%), CONY (101.35%), ULTY (100.99%), YMAX (51.97%), YMAG (62.33%) and Others
-
Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific Meetings
-
Cathay Cargo Leveraged Descartes Air Cargo Tracking Solution to Help Support Safe Journey of Giant Pandas
-
Kraken Robotics Receives $13 Million of Subsea Battery Orders
-
Nova Minerals Drills 39m @ 5.4 g/t Au from Surface at the RPM Deposit on its Estelle Gold-Antimony Project, in Alaska
-
Taboola to Release Third Quarter 2024 Financial Results and Host Earnings Conference Call on November 7, 2024
-
Nanjing Medical University Celebrates 90th Anniversary
-
Chinese Anime IP Ignites Cultural and Tourism Consumption Vitality in Qianhai, Shenzhen
